Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Chart tumour evolution using cutting-edge long-read and single-cell multiomics Who we are The Integrative Cancer Genomics lab (Jonas Demeulemeester) is embedded within the VIB – KU Leuven Center
-
includes https://doi.org/10.1101/2025.0... and https://doi.org/10.64898/2025.... Profile You have: An MSc (or equivalent) in structural biology, cell biology, biophysics, bioengineering
-
data. We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in vivo during developmental and disease. These technologies are a game-changer in the speed
-
. YOUR PROFILE Ph.D. in life sciences (earned within the past 3 years). Required: experience with human cell line engineering; molecular biology expertise is a plus. Excellent English communication skills
-
work includes https://doi.org/10.1101/2025.0... and https://doi.org/10.64898/2025.... Profile You have: A PhD in structural biology, cell biology, biophysics, bioengineering, or a related
-
provide hands on support in tasks related to mouse experiments, molecular biology and cell culture. Profile The candidate: Should have a (professional) bachelor’s degree, Master’s or PhD degree in
-
is to integrate genetics, cell biology, genomics, and bio-computing to unravel plant biological processes and to further translate this knowledge into value for society. Please visit us at
-
supported by a Foundation against Cancer (2025 – 2030). We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in tumor-associated macrophages (TAMs) in vivo. We
-
to the unit (e.g., proteomics, biochemistry, biophysics, metabolomics, imaging). Experience with cell culture and viral work. Experience with animal work (FELASA B certificate) is a plus. Proven experience in
-
prodromal cohorts and link them to clinical readouts and α-synuclein reactivity. Use cutting-edge single-cell and immune-profiling approaches, linked to clinical phenotyping, to discover early biomarkers and